project id: TCGA-BRCA; case submitter id: TCGA-A2-A25A; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.2; rna integrity number: 7.9; spectrophotometer method: UV Spec; age at index: 44; days to birth: -16084; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1959; age at diagnosis: 16084; ajcc pathologic m: M0; ajcc pathologic n: N0 (i-); ajcc pathologic stage: Stage IIA; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 3276.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8520/3; primary diagnosis: Lobular carcinoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2003; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2927; days to sample procurement: 0; initial weight: 160.0; portion submitter id: TCGA-A2-A25A-01A-12; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 2.0; percent stromal cells: 28.0; percent tumor cells: 70.0; percent tumor nuclei: 80.0;